Tom Looby, CEO at Conavi Medical

https://www.conavi.com/novasight/
Latest in Home
Today in Manufacturing Podcast
Sponsored
Today in Manufacturing Podcast
April 1, 2025
CAR T-cell therapy involves collecting a patient’s immune cells and engineering them to recognize and destroy cancer cells before returning them to the body through an IV infusion. This process takes place at the Roswell Park GMP Engineering & Cell Manufacturing Facility (GEM), one of the largest of its kind in the United States.
Survey Shows Majority of Americans Unaware of Innovative Cancer Treatment
April 17, 2025
The Johnson & Johnson logo appears above a trading post on the floor of the New York Stock Exchange, Monday, July 12, 2021.
Johnson & Johnson Expects $400 Million in Tariff-Related Costs
April 15, 2025
This photo provided by eGenesis on Jan. 18, 2024 shows a genetically modified pig liver in Massachusetts before transportation to the University of Pennsylvania in Philadelphia in December 2023.
FDA OKs Trial of Pig Livers as Dialysis-Like Treatment for Liver Failure
April 15, 2025
Related Stories
Ap25092742032433
Home
Draft Budget Plan Proposes Deep Cuts Across Federal Health Programs
I Stock 2191975796
Home
Medtronic Partners with Methinks AI to Advance Stroke Care Development
Ap25091780103402
Home
Federal Judge to Temporarily Block Billions in Health Funding Cuts to States
Industrial Media Unboxing Video
Sponsor Content
Industrial Media Unboxing Video
More from Tom Looby, CEO at Conavi Medical
Today in Manufacturing Podcast
Sponsored
Today in Manufacturing Podcast
Today in Manufacturing has a new podcast brought to you by the editors of Industrial Media. In each episode, we discuss the five biggest stories in manufacturing, and the implications they have on the industry moving forward.
April 1, 2025